Back to News
Mergers & Acquisitions

Drinks With The Deal: Albrecht Discusses Challenge of Balancing Life, Law

|
Published: November 16th, 2023
Eli Albrecht, a partner at SMB Law Group, talks about creating an M&A practice outside of a large law firm on this week’s Drinks With The Deal podcast.

As an associate at Gibson, Dunn & Crutcher LLP, Eli Albrecht said on this week’s Drinks With The Deal podcast, he had a powerful conversation with a partner at the firm. The lawyer, Albrecht said, was going through a difficult divorce, and he told Albrecht: “Big Law partnership is a mirage. You think you’re going to get there; you think you’re going to be happy once you arrive. It’s not there.”

Albrecht, now a partner at SMB Law Group LLP, has openly discussed “the challenges that I faced as someone who wanted to be a successful Big Law lawyer while being a dedicated father, husband and person of faith” on social media, as he said on the podcast. “Being a great lawyer cannot be at the cost of the life we have outside of work and the people who love us and want to be with us.”

Earlier this year, he moved to SMB, a “remote-first” law firm that focuses on corporate work for small and midsize businesses. There, Albrecht specializes in deals of less than $100 million, which in other respects are similar to the ones he worked on at Gibson Dunn.

The ability to work from home has been “absolutely transformative” for me, Albrecht said, because it’s allowed him to deepen his relationships with his wife and three children. “When I’m fully engaged with the parts of me that need nurturing,” he said, “I’m a much better lawyer and a much better human.”

Listen to the podcast with Eli Albrecht below:

More podcasts from The Deal are available on iTunesSpotify and on TheDeal.com

More From Mergers & Acquisitions

Mergers & Acquisitions

Dow Considers Options for Infrastructure Assets

By Tom Terrarosa
|
Published: December 6th, 2023
The company is working with two bulge-bracket advisers to build a potential sale process around Gulf Coast infrastructure that sources said could amount to around $5 billion.
Mergers & Acquisitions

Resetting Expectations for IFF's Pharma Exit

By Tom Terrarosa
|
Published: December 5th, 2023
The chemicals conglomerate is said to need a deal for its pharma business, but the market may deliver it a disappointment on valuation.
Mergers & Acquisitions

Talking M&A: Competition Complexities

By The Deal Contributors
|
Published: November 20th, 2023
Following a number of crackdowns from global competition regulators, Baker McKenzie partners Duffy Lorenz and Creighton Macy share their experiences, insights and advice for clients looking to run a smooth deal process and minimize unexpected antitrust curveballs.